Key result
Patients with positive amiodarone-induced pulmonary toxicity CT scores exhibited lower diffusion capacity for carbon monoxide compared to those with negative scores.
Why the study?
Does chest computed tomography (CT) scoring predict the severity of amiodarone-induced pulmonary toxicity in patients receiving long-term amiodarone therapy?
Cohort (n=34)
No
Does chest computed tomography (CT) scoring predict the severity of amiodarone-induced pulmonary toxicity in patients receiving long-term amiodarone therapy?
Chest CT scoring is a feasible and useful diagnostic index for assessing the severity of amiodarone-induced pulmonary toxicity in patients on long-term therapy.
Answers are grounded in this paper and cite their sources.
Supports CT scoring for amiodarone pulmonary toxicity severity assessment; hypothesis-generating and requires prospective validation.
BACKGROUND/AIMS: Amiodarone is one of the most widely used antiarrhythmic agents; however, amiodarone-induced pulmonary toxicity (APT) can be irreversible and sometimes fatal. The aim of this study was to evaluate the feasibility of chest computed tomography (CT) as a diagnostic tool for APT and to assess the utility of the CT APT score as an index for predicting the severity of APT. METHODS: Patients underwent amiodarone treatment for various reasons, most often atrial fibrillation, for more than 2 years, and those that received a cumulative dose > 100 g were enrolled. A total of 34 patients who underwent chest CT between December 2011 and June 2012 were enrolled, whether or not they had clinical symptoms. The APT CT score was defined as the number of involved regions in the lung, which was divided into 18 regions (right and left, upper, middle, and lower, and central, middle, and peripheral). The CT findings were evaluated according to the total dose and duration of amiodarone treatment and the results of a pulmonary function test. Clinical symptoms and outcomes were also evaluated according to APT CT scores. RESULTS: Seven patients had positive APT CT scores (interstitial fibrosis in five, organizing pneumonia in one, and mixed interstitial fibrosis and organizing pneumonia in one), and these patients exhibited significantly lower diffusion capacity for carbon monoxide in the lungs compared with patients without an increased APT CT score (70.2% ± 6.9% vs. 89.7% ± 19.4%; p = 0.011). Three of the seven patients experienced overt APT that required hospital admission. CONCLUSIONS: Chest CT is a useful diagnostic tool for APT, and the APT CT score might be a useful index for assessing the severity of APT.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2014) conducted a cohort in Amiodarone-induced pulmonary toxicity (n=34). Positive APT CT score vs. Negative APT CT score was evaluated on Diffusion capacity for carbon monoxide (DLCO) (p=0.011). Patients with positive amiodarone-induced pulmonary toxicity CT scores exhibited lower diffusion capacity for carbon monoxide compared to those with negative scores.
Synapse has enriched 10 related papers. Consider them for comparative context: